This proton pump inhibitor was already approved for adolescents between the ages of 12 to 17.
这种质子泵抑制剂已经被批准用于12岁至17岁的青少年。
Since the first proton pump inhibitor (Omeprazole) came into the market in 1988, PPIs have been considered as the drugs of first choice for treatment of patients with various acid-related diseases.
自第一个质子泵抑制剂(PPI)奥美拉唑于1988年上市以来，PPI已成为酸相关性疾病治疗的首选药物。
Proton pump inhibitor (PPI) is considered as the standard treatment for acid-related disorders.
质子泵抑制剂的应用是酸相关疾病的标准治疗。
应用推荐